Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Jean-Marie Michot

Jean-Marie Michot

MD
Gustave Roussy Institute
Long-term follow-up of patients aged 80 or older with DLBCL treated with mini-CHOP plus anti-CD20 5:20
Long-term follow-up of patients aged 80 or older with DLBCL treated with mini-CHOP plus anti-CD20
Jean-Marie Michot • 17 Dec 2024
FS118 shows activity in patients with R/R DLBCL post-CAR-T: findings from a Phase II trial 1:51
FS118 shows activity in patients with R/R DLBCL post-CAR-T: findings from a Phase II trial
Jean-Marie Michot • 17 Dec 2024
Longer follow-up of a Phase I trial combining golcadomide with rituximab in R/R DLBCL 3:33
Longer follow-up of a Phase I trial combining golcadomide with rituximab in R/R DLBCL
Jean-Marie Michot • 17 Dec 2024
Golcadomide ± rituximab for R/R NHL: Phase I/II trial interim analysis 2:47
Golcadomide ± rituximab for R/R NHL: Phase I/II trial interim analysis
Jean-Marie Michot • 16 Jun 2023
The content of VJHemOnc is intended for healthcare professionals